Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
12/2005
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005CN1705654A Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl-and didesmethyl-metabolites of citalopram
12/07/2005CN1230442C GnRh antagonists being modified in positions 5 and 6
12/07/2005CN1230418C Selective androgen receptor modulators and methods of use thereof
12/07/2005CN1230163C 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
12/07/2005CN1230156C Fibrauretine dispersant tablet and its preparing method
12/06/2005US6972321 Monomeric protein of the TGF-β family
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972194 culturing cells in envelopes comprising acrylic amide homopolymers, for use in immunization against tumor cells and prophylaxis of diabetes; vaccines
12/06/2005CA2349338C Novel macrolide antibiotics
12/06/2005CA2347512C Adenine derivatives
12/06/2005CA2289599C Substituted heterocyclic compounds, method for preparing and compositions containing same
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267183 Selective estrogen receptor modulators
12/01/2005US20050267165 Il-8 receptor antagonists
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267147 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/01/2005US20050267133 Pyrazolopyrimidines as kinase inhibitors
12/01/2005US20050267126 Compounds derived from aryl carbamates, preparation thereof and uses of same
12/01/2005US20050267112 intravenous or oral administration; hypotensive agents; enzyme inhibitors of cGMP-metabolizing phosphodiesterases
12/01/2005US20050267081 Use of a combination of ethinyloestradiol and chlormadinone acetate to produce a pharmaceutical preparation
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266007 Activated form of ultra-low doses of monoclonal, polyclonal, or natural antibodies to the prostate-specific antigen; prepared by multiple consecutive dilutions and exposure to external factors; homeopathic technology; urogenital disorders; side effect reduction; cattle extracts; synthetic
11/2005
11/30/2005EP1600163A1 Use of the neurotoxic component of botulinum toxins for the treatment of spastic muscle
11/30/2005EP1599167A2 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
11/30/2005EP1458381B1 Triazoles as oxytocin antagonists
11/30/2005EP1432708B1 Preparation and use of 1,5,6,7-tetrahydropyrrolo 3,2-c]pyridine derivatives for treatment of obesity
11/30/2005EP1401839B9 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta [a] naphthalene
11/30/2005EP1392337B1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
11/30/2005EP1353700B1 Compositions of estrogen-cyclodextrin complexes
11/30/2005EP1313511B1 Testosterone ester formulation for human use
11/30/2005EP1289534B1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/30/2005CN1703401A Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1703393A Spiro compounds, medicinal compositions containing the same and intermediates of the compounds
11/30/2005CN1229375C Nicotinic acetylcholine receptor inhibitor, its prepn. and application
11/30/2005CN1229370C Novel derivatives of flavones, xanthones and coumarins
11/30/2005CN1229349C Pyridine-3-carboxylic acid derivative
11/30/2005CN1229331C Inhibitor of monoamine uptake
11/30/2005CN1229125C Medication for irregular menses and dysmenorrhea
11/30/2005CN1229120C Carthamus flower medicated liquor
11/30/2005CN1229114C Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
11/29/2005US6969729 An indole or benz(g)indole-2,3-dione-3-oxime compounds; therapeutic treatment of respiratory disorders, urogenital disorders, cardiovascular disorders, brain and psychological disorders, gastrointestinal disorders
11/29/2005US6969724 Compounds
11/29/2005US6969719 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders
11/29/2005US6969718 17-β hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
11/29/2005US6969717 Azaindole kinase inhibitors
11/29/2005US6969708 Process for the preparation of a high purity composition comprising (7α, 17α)- 17-hydroxy- 7-methyl- 19-nor-17-pregn-5(10)-en-20-yn-3-one
11/29/2005CA2355493C Therapeutic compositions comprising excess enantiomer
11/24/2005US20050261502 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders
11/24/2005US20050261377 Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
11/24/2005US20050261338 Beta2-adrenergic receptor agonists
11/24/2005US20050261323 Medical uses of novel carbamate-substituted pyrazolopyridine derivatives
11/24/2005US20050261313 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction
11/24/2005US20050261279 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
11/24/2005US20050261277 Pentacyclic oxepines and derivatives thereof, compositions and methods
11/24/2005US20050260228 Vaccines absorbable by the transmucosal way
11/24/2005CA2566185A1 Formulations with controlled release of active ingredient
11/23/2005EP1598077A1 Use of the neurotoxic component of botulinum toxins for the treatment of a spastic muscle
11/23/2005EP1598069A2 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
11/23/2005EP1597260A1 Triazole compounds useful in therapy
11/23/2005EP1597229A2 Pyrrolidine derivatives as oxytocin antagonists
11/23/2005EP1596881A1 Use of human chorionic gonadotropin in the treatment of symptoms caused by endometriosis
11/23/2005EP1596858A1 Ip receptor antagonists for the treatment of pathological uterine conditions
11/23/2005EP1596850A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function
11/23/2005EP1377550B9 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/23/2005EP1320372B1 Use of sulfatides for treating diabetes
11/23/2005EP1296686B1 Praziquantel compositions for treating diseases caused by a coccidia
11/23/2005EP1001797B9 Soya extract, process for its preparation and pharmaceutical composition
11/23/2005EP0770129B1 Zinc finger protein derivatives and methods therefor
11/23/2005EP0732934B1 Long-acting injection suspensions of an lhrh analogue and a process for their preparation
11/23/2005CN1701068A Novel compounds and their use
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1700934A Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
11/23/2005CN1700927A Pharmaceutical composition for treating menorrhagia and method for preparing the same
11/23/2005CN1700923A Multi-substituted selective androgen receptor modulators and methods of use thereof
11/23/2005CN1699346A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/23/2005CN1698894A Tumor necrosis factor antagonists and their use in endometriosis
11/23/2005CN1698602A Usage of pyrazoline derivant in the drug preparation for preventing and/or treating cell breeding disease
11/23/2005CN1698601A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use
11/23/2005CN1228076C Chinese traditional medicine for treating preceded menstrual cycle and excessive menses due to blood heat
11/23/2005CN1228067C Biochemical medicament of araliaceae plant and its preparation method
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/17/2005WO2005108400A1 Pyridoquinazoline derivatives having heterobicyclic substituents
11/17/2005WO2005108399A1 Imidazopyridine compound
11/17/2005WO2005107810A2 Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
11/17/2005US20050256308 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds
11/17/2005US20050256201 Phenethanolamine derivatives
11/17/2005US20050256167 Preparation and use of imidazole derivatives for treatment of obesity
11/17/2005US20050256122 Substituted pyridazinones
11/17/2005US20050256110 Cyanopyrroles
11/17/2005US20050255573 An in vitro method of maintaining a mouse or human pluripotent cell in a pluripotent state by increasing expression of a gene that encodes a factor which acts intracellularly and maintainspluripotency, where the factor is a polypeptide of the sequence of SEQ ID NO: 4; cultures
11/17/2005US20050255529 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/17/2005US20050255156 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
11/17/2005CA2566699A1 Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
11/17/2005CA2566184A1 Imidazopyridine compound
11/16/2005EP1595867A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
11/16/2005EP1594989A2 Methods for the early diagnosis of ovarian cancer
11/16/2005EP1594841A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
1 ... 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 ... 557